TRLVNYSEMedicinal Chemicals & Botanical ProductsFiscal year ends December 31

Trulieve Cannabis Corp.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026

$10.28+0.27 (+2.70%)

Close on Oct 19, 2026

Market cap: $1.98B
P/E (TTM): –
Dividend yield: –

Trulieve Cannabis Corp. balance sheet

Annual Quarterly

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31
Cash & Equivalents	256	239	201	207	227	147	92	–
Short-Term Investments	0	60	0	–	–	–	–	–
Cash & Short-Term Investments	256	299	201	207	227	147	92	–
Receivables	10	8.29	6.70	6.51	8.85	0.31	–	–
Inventory	242	231	213	277	212	98	–	–
Prepaid Expenses & Other	18	23	18	11	68	16	–	–
Other Current Assets	25	26	24	51	12	2.96	–	–
Total Current Assets	563	605	477	594	524	261	–	–
Property, Plant & Equipment	670	716	676	743	780	314	–	–
Gross Property, Plant & Equipment	1,017	987	876	869	844	344	–	–
Accumulated Depreciation	-346	-271	-199	-126	-64	-30	–	–
Equity Method Investments	0	–	–	–	–	–	–	–
Operating Lease Right-of-Use Assets	108	120	96	99	126	30	–	–
Goodwill	484	484	484	791	765	67	7.32	–
Intangible Assets	798	859	917	985	1,118	93	30	–
Other Long-Term Assets	10	20	10	13	18	7.53	–	–
Total Assets	2,696	2,870	2,729	3,400	3,411	810	–	–
Accounts Payable	83	20	28	16	15	9.25	–	–
Current Portion of Leases	13	12	10	10	9.84	3.28	–	–
Current Income Taxes Payable	–	–	0	50	28	5.88	–	–
Deferred Revenue (Current)	9.59	7.50	0.80	9.46	7.17	7.18	–	–
Total Current Liabilities	127	138	115	210	169	76	–	–
Long-Term Debt	91	112	116	94	6.46	4.00	–	–
Long-Term Leases	108	117	92	100	122	28	–	–
Operating Lease Liabilities	121	130	102	113	132	31	–	–
Deferred Tax Liabilities	178	197	207	225	251	15	–	–
Other Long-Term Liabilities	11	4.95	7.09	6.82	8.40	3.92	–	–
Total Liabilities	1,553	1,621	1,320	1,473	1,263	362	–	–
Total Debt	91	112	116	94	6.46	4.00	–	–
Common Stock	0	0	0	0	–	–	–	–
Additional Paid-In Capital	2,073	2,057	2,055	2,045	2,008	328	–	–
Retained Earnings	-912	-796	-641	-114	138	120	–	–
Shareholders' Equity	–	–	–	–	–	448	133	–
Noncontrolling Interest	-18	-12	-5.86	-3.46	1.55	0	–	–
Total Equity	1,143	1,249	1,409	1,928	2,147	448	133	79
Total Liabilities & Equity	2,696	2,870	2,729	3,400	3,411	810	–	–
Shares Outstanding(shares)	192	191	186	186	181	120	–	–
Loans, Net	–	–	14	13	–	–	–	–
Allowance for Credit Losses	4.89	7.22	0	0	–	–	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 59.5%
Operating margin: -24.3%
Net margin: –
Return on equity, FY2025: –

Financial strength

Current ratio: 5.94
Debt to equity: –
Debt to assets: 4.3%
Cash to current liabilities: 342.3%

Valuation

P/E ratio: –
Price to sales: 1.74
Price to book: –
Dividend yield: –